Functional characterization of adenosine receptors in the nucleus tractus solitarius mediating hypotensive responses in the rat

British Journal of Pharmacology

Volumn 117, Issue 2, 1996, Pages 305-308

  White, Paul J ^a   Rose'Meyer, Roselyn B ^a   Hope, Wendy ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adenosine receptors; Blood pressure; N6 cyclopentyl adenosine; Nucleus tractus solitarius

Indexed keywords

2 ANILINOADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BRAIN RECEPTOR; CYCLOHEXYLADENOSINE; N [2 (DIMETHYLAMINO)ETHYL] N METHYL 4 (1,3 DIPROPYLXANTHIN 8 YL)BENZENESULFONAMIDE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

EID: 0030061333     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15191.x     Document Type: Article

References (25)

1. BARRACO, R.A. & PHILLIS, J.W. (1991). Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacol., 30, 403-407.
2. BRUNS, R.F., LU, G.H. & PUGSLEY, T.A. (1986). Characterisation of the A2 adenosine receptor labelled by (3H)-NECA in striatal membranes. Mol. Pharmacol., 29, 331-346.
3. BISSERBE, J.C., PASCAL, O., DECKERT, J. PUGSLEY, T.A. (1986). Characterisation of the A2 adenosine receptor labelled by (3H)-NECA in striatal membranes. Mol. Pharmacol., 29, 331-346.
4. COLLIS, M.G. & HOURANI, S.M.O. (1993). Adenosine receptor subtypes. Trends Pharmacol. Sci. Rev., 14, 360-366.
5. DALY, J.W., BUTTS-LAMB, P. & PADGETT, W. (1983). Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol., 3, 69-80.
6. EVONUIK, G., VON BORSTEL, R.W. & WURTMAN, R.J. (1986). Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)-theophylline. J. Pharmacol. Exp. Ther., 240, 428-442.
7. FERRE, S., VON EULER, G., JOHANSONN, B. & FREDHOLM, B.B. (1992). Adenosine-dopamine interactions in the brain. Neuroscicnce, 51, 501-512.
8. FOZARD, J.R. & HANNON, J.P. (1994). BW-A522 blocks adenosine A3 receptor-mediated hypotensive responses in the rat. Eur. J. Pharmacol., 252, R5-6.
9. JARVIS, M.K. & WILLIAMS, M. (1990). In Adenosine and Adenosine Receptors ed. Williams, M. p. 289. New Jersey: Humana.
10. KAMIKAWA, Y., CLIN, W.H. & SU, C. (1980). Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur. J. Pharmacol., 66, 347-352.
11. 6-cyclopentyladenosine in the rat. J. Pharmacol. Exp. Ther., 268, 616-624.
12. MATIAS, A., ALBINO-TEIXEIRA, A., POLONIA, J. & AZEVEDO, I. (1991). Long term administration of 1,3-dipropyl-8-sulfophenyl-xanthine causes arterial hypotension. Eur. J. Pharmacol., 193, 101-108.
13. MOSQUEDA-GARCIA, R., TESTING, C.J., APPALSAMY, C.B. & ROBERTSON, D. (1991). Cardiovascular excitatory effects of adenosine in the nucleus of the solitary tract. Hypertension, 18, 494-502.
14. MUNGER, K.A. & JACKSON, E.K. (1994). Effects of selective a1 receptor blockade on glomerular haemodynamics; involvement of renin-angiotensin system. Am. J. Physiol., 267, 783-790.
15. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. Figure 63. Sydney: Academic Press.
16. RABKIN, S.W. (1990). D-ala-2-Me-Phe-4-Met-(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depression. Gen. Pharmacol., 22, 479-484.
17. ST. LAMBERT, J.H., DAWID-MILNER, M.S., SILVA-CARVALO, L. & SPYER, K.M. (1994). Action of adenosine receptor antagonists in the cardiovascular response to defence area stimulation in the rat. Br. J. Pharmacol., 113, 159-164.
18. TALLARIDA, R.J. & MURRAY, R.B. (1987). Manual of Pharmacological Calculations with Computer Progams. Berlin: Springer Verlag.
19. TALMAN, W.T. & LEWIS, S.J. (1991). Altered cardiovascular responses to glutamate and acelylcholine microinjected into the nucleus tractus solitarii of the SHR. Clin. Exp. Hypertens. A., 13, 661-668.
20. TAO, S. & ABDEL-RAHMAN, A.A. (1993). Neuronal and cardiovascular responses to adenosine microinjected into the nucleus tractus solitarius. Brain Res. Bull., 32, 407-417.
21. VAN CALKER, D., MULLER, M. & HAMPRECHT, B. (1979). Adenosine regulates two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 33, 999-1005.
22. VON KUGELGEN, I., SPATH, L. & STARKE, K. (1994). Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in the rat brain cortex. Br. J. Pharmacol., 113, 815-822.
23. WHITE, P.J., ROSE'MEYER, R.B. & HOPE, W. (1993). The role of adenosine in the cardiovascular actions of morphine. Clin. Exp. Pharmacol. Physiol., suppl., 1, 77.
24. WILLIAMS, M. (1989). Adenosine antagonists. Med. Res. Rev., 9, 219-243.
25. ZHOU, Q-Y, LI, C., OLAH, M.E., JOHNSON, R.A., STILES, G.L. & CIVELLI, O. (1992). Molecular cloning and characterization of an adenosine receptor: the adenosine A3 receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 7432.